WallStreetZenWallStreetZen

NASDAQ: LBPH
Longboard Pharmaceuticals Inc Earnings & Revenue

LBPH earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$54.4M
Current Profit Margin
0%

LBPH Return on Equity

Current Company
-97.5%
Current Industry
-63.5%
Current Market
188%
LBPH's Return on Equity (-97.5%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when LBPH announces earnings.

LBPH Return on Assets

Current Company
-85.2%
Current Industry
2.9%
LBPH is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

LBPH Return on Capital Employed

Current Company
-132.99%
Current Industry
19.5%
LBPH's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

LBPH vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
LBPH$0.00-$54.42M-$54.42MN/AN/A
ELVN$0.00-$70.98M-$71.58MN/AN/A
AUPH$175.51M-$63.05M-$78.02M+227.90%N/A
PLRX$1.58M-$155.84M-$161.34M-59.21%N/A
ARCT$166.80M-$41.52M-$29.73M+60.31%N/A

LBPH earnings dates

Next earnings date
May 23, 2024

Longboard Pharmaceuticals Earnings & Revenue FAQ

What were LBPH's earnings last quarter?

On Invalid Date, Longboard Pharmaceuticals (NASDAQ: LBPH) reported Q4 2023 earnings per share (EPS) of -$0.62, up 6.06% year over year. Total Longboard Pharmaceuticals earnings for the quarter were -$15.03 million. In the same quarter last year, Longboard Pharmaceuticals's earnings per share (EPS) was -$0.66.

If you're new to stock investing, here's how to buy Longboard Pharmaceuticals stock.

What was LBPH's earnings growth in the past year?

As of Q2 2024, Longboard Pharmaceuticals's earnings has grown year over year. Longboard Pharmaceuticals's earnings in the past year totalled -$54.42 million.

What is LBPH's earnings date?

Longboard Pharmaceuticals's earnings date is Invalid Date. Add LBPH to your watchlist to be reminded of LBPH's next earnings announcement.

What was LBPH's revenue last quarter?

On Invalid Date, Longboard Pharmaceuticals (NASDAQ: LBPH) reported Q4 2023 revenue of $0.00 up N/A year over year. In the same quarter last year, Longboard Pharmaceuticals's revenue was $0.00.

What was LBPH's revenue growth in the past year?

As of Q2 2024, Longboard Pharmaceuticals's revenue has grown null year over year. Longboard Pharmaceuticals's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.